KYTX
Kyverna Therapeutics, Inc.
6.20$
+0.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -0.86 | -1.40 | -0.08 | -2.98 | -3.47 | |
| 0.02 | 0.04 | 0.00 | 0.06 | 0.04 | |
| 0.28 | 0.04 | 0.00 | 0.22 | 0.23 | |
| -0.17 | -0.40 | 0.01 | 0.20 | -0.02 | |
| 0.05 | 0.03 | 0.00 | 0.06 | 0.00 | |
| -0.05 | -0.55 | -0.01 | -4.20 | 0.90 | |
| 0.00 | -0.01 | 0.00 | -0.02 | -0.02 | |
| 2.81 | 0.46 | 0.09 | 8.79 | 3.19 | |
| 1.90 | -1.49 | 0.00 | 1.62 | 0.62 | |
| -0.91 | -1.43 | -0.08 | -3.04 | -3.47 |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.